Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Pediatrics
|
November 1, 1981
Hyperprolactinemia causing primary amenorrhea
A Sadeghi-Nejad, J I Wolfsdorf, B J Biller, et al.
Veterinary and Comparative Oncology
|
November 3, 2015
Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs
R M Rasmussen, I D Kurzman, B J Biller, et al.
JAMA
|
August 17, 1984
Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma
E F Rodman, M E Molitch, K D Post, et al.
Veterinary Immunology and Immunopathology
|
January 17, 2007
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer
B J Biller, R E Elmslie, R C Burnett, et al.
American Journal of Veterinary Research
|
October 11, 2001
Telomerase activity as a marker for malignancy in feline tissues
C D Cadile, B E Kitchell, B J Biller, et al.
Veterinary and Comparative Oncology
|
June 17, 2017
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma
T Laver, C A London, D M Vail, et al.
JAMA
|
July 13, 1979
Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea
K D Post, B J Biller, L S Adelman, et al.
Veterinary and Comparative Oncology
|
May 6, 2016
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study
M A Pellin, R M Wouda, K Robinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C
A C Moses, M E Molitch, C T Sawin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1980
Galactorrhea, oligo/amenorrhea, and hyperprolactinemia in patients with craniopharyngiomas
L P Kapcala, M E Molitch, K D Post, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Pediatrics
|
November 1, 1981
Hyperprolactinemia causing primary amenorrhea
A Sadeghi-Nejad, J I Wolfsdorf, B J Biller, et al.
Veterinary and Comparative Oncology
|
November 3, 2015
Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs
R M Rasmussen, I D Kurzman, B J Biller, et al.
JAMA
|
August 17, 1984
Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma
E F Rodman, M E Molitch, K D Post, et al.
Veterinary Immunology and Immunopathology
|
January 17, 2007
Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer
B J Biller, R E Elmslie, R C Burnett, et al.
American Journal of Veterinary Research
|
October 11, 2001
Telomerase activity as a marker for malignancy in feline tissues
C D Cadile, B E Kitchell, B J Biller, et al.
Veterinary and Comparative Oncology
|
June 17, 2017
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma
T Laver, C A London, D M Vail, et al.
JAMA
|
July 13, 1979
Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea
K D Post, B J Biller, L S Adelman, et al.
Veterinary and Comparative Oncology
|
May 6, 2016
Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study
M A Pellin, R M Wouda, K Robinson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1981
Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C
A C Moses, M E Molitch, C T Sawin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1980
Galactorrhea, oligo/amenorrhea, and hyperprolactinemia in patients with craniopharyngiomas
L P Kapcala, M E Molitch, K D Post, et al.
Page
of 3